Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 065422
Company: VISTAPHARM
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION;ORAL Prescription AA No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/07/2011 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/27/2012 SUPPL-1 Labeling-Package Insert

Label is not available on this site.

NYSTATIN

SUSPENSION;ORAL; 100,000 UNITS/ML
TE Code = AA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION;ORAL Prescription No AA 062517 FOUGERA PHARMS INC
NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION;ORAL Prescription No AA 064042 HI TECH PHARMA
NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION;ORAL Prescription No AA 065148 LANNETT CO INC
NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION;ORAL Prescription No AA 203621 PHARM ASSOC
NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION;ORAL Prescription No AA 062876 TARO PHARM
NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION;ORAL Prescription No AA 064142 VISTAPHARM
NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION;ORAL Prescription No AA 065422 VISTAPHARM
NYSTATIN NYSTATIN 100,000 UNITS/ML SUSPENSION;ORAL Prescription No AA 062512 WOCKHARDT BIO AG

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English